[go: up one dir, main page]

NO983090D0 - Terapeutiske forbindelser - Google Patents

Terapeutiske forbindelser

Info

Publication number
NO983090D0
NO983090D0 NO983090A NO983090A NO983090D0 NO 983090 D0 NO983090 D0 NO 983090D0 NO 983090 A NO983090 A NO 983090A NO 983090 A NO983090 A NO 983090A NO 983090 D0 NO983090 D0 NO 983090D0
Authority
NO
Norway
Prior art keywords
therapeutic compounds
therapeutic
compounds
Prior art date
Application number
NO983090A
Other languages
English (en)
Other versions
NO983090L (no
Inventor
Stanley Dawes Chamberlain
George Walter Koszalka
Jeffrey H Tidwell
Nanine Agneta Van Draanen
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO983090D0 publication Critical patent/NO983090D0/no
Publication of NO983090L publication Critical patent/NO983090L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052—Imidazole radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO983090A 1996-01-05 1998-07-03 Terapeutiske forbindelser NO983090L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9600143.3A GB9600143D0 (en) 1996-01-05 1996-01-05 Therapeutic compounds
PCT/GB1996/003151 WO1997025337A1 (en) 1996-01-05 1996-12-19 Therapeutic compounds

Publications (2)

Publication Number Publication Date
NO983090D0 true NO983090D0 (no) 1998-07-03
NO983090L NO983090L (no) 1998-09-01

Family

ID=10786611

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983090A NO983090L (no) 1996-01-05 1998-07-03 Terapeutiske forbindelser

Country Status (21)

Country Link
US (2) US6204249B1 (no)
EP (1) EP0876389A1 (no)
JP (1) JP2000515119A (no)
KR (1) KR19990077041A (no)
CN (1) CN1214049A (no)
AP (1) AP9801286A0 (no)
AU (1) AU729541B2 (no)
BR (1) BR9612413A (no)
CA (1) CA2241993A1 (no)
CZ (1) CZ212698A3 (no)
EA (1) EA001770B1 (no)
GB (1) GB9600143D0 (no)
HU (1) HUP9904301A3 (no)
IS (1) IS4789A (no)
MX (1) MX9805441A (no)
NO (1) NO983090L (no)
NZ (1) NZ324380A (no)
OA (1) OA10707A (no)
PL (1) PL327732A1 (no)
TR (1) TR199801289T2 (no)
WO (1) WO1997025337A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2223814A1 (en) * 1995-08-18 1997-02-27 John C. Drach 5'-substituted-ribofuranosyl benzimidazoles as antiviral agents
GB9600143D0 (en) * 1996-01-05 1996-03-06 Wellcome Found Therapeutic compounds
US6413938B1 (en) 1997-02-13 2002-07-02 The Regents Of The University Of Michigan Benzimidazole derivatives for the treatment of viral infections
ATE238998T1 (de) 1997-02-25 2003-05-15 Us Gov Health & Human Serv Substituierte benzimidazole als nicht-nucleoside reverse transcriptase inhibitore
CN1272113A (zh) 1997-07-30 2000-11-01 密歇根大学董事会 作为抗病毒剂的来苏呋喃糖基苯并咪唑类化合物
GB9807355D0 (en) 1998-04-07 1998-06-03 Glaxo Group Ltd Antiviral compound
GB9807354D0 (en) 1998-04-07 1998-06-03 Glaxo Group Ltd Antiviral compound
GB0008939D0 (en) 2000-04-11 2000-05-31 Glaxo Group Ltd Process for preparing substituted benzimidazole compounds
ATE537181T1 (de) * 2003-12-26 2011-12-15 Kissei Pharmaceutical Benzimidazolderivate und deren medizinische verwendungen
WO2009044886A1 (ja) 2007-10-05 2009-04-09 Api Corporation リボフラノース誘導体の製造方法
US12043644B2 (en) * 2020-06-23 2024-07-23 Biometrix Technology Inc Benzimidazole derivatives, preparation method thereof and use thereof as anti-cancer agent or anti-virus agent comprising the same
WO2024081308A1 (en) 2022-10-12 2024-04-18 Takeda Pharmaceutical Company Limited Method of preparing maribavir
WO2024103979A1 (zh) * 2022-11-17 2024-05-23 北京凯因科技股份有限公司 一种抑制疱疹病毒的化合物
CN119119151A (zh) * 2024-09-04 2024-12-13 斯坦德药典标准物质研发(湖北)有限公司 一种马立巴韦的制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE130030C (no)
US3399987A (en) 1965-08-02 1968-09-03 United States Borax Chem 2-alkylaminobenzimidazoles as herbicides
CH443777A (de) 1965-08-06 1968-02-15 Agripat Sa Verfahren zum Schützen textiler Keratinfasern vor Insektenfrass und Mittel zur Durchführung dieses Verfahrens
US3655901A (en) 1970-07-30 1972-04-11 Merck & Co Inc Method of inhibiting the formation of phenylethanalamine-n-methyl transferase with 2-aminobenzimidazoles
US4002623A (en) 1974-08-07 1977-01-11 Pfizer Inc. Anti-inflammatory 1-[3-(dialkylamino)propyl]-2-acylaminobenzimidazoles and 2-acylamino-3-[3-(dialkylamino)-propyl]imidazo[4,5-b]pyridines
FR2551442B1 (fr) 1983-09-05 1987-04-30 Centre Nat Rech Scient Nouveaux derives furaniques, leur preparation et leur application
DK405988A (da) 1987-07-29 1989-01-30 Hoffmann La Roche Benzimidazolderivater
IT1226100B (it) 1988-07-07 1990-12-10 Dompe Farmaceutici Spa Derivati benzimidazolici farmacologicamente attivi.
SE9003151D0 (sv) 1990-10-02 1990-10-02 Medivir Ab Nucleoside derivatives
US5248672A (en) 1990-11-01 1993-09-28 The Regents Of The University Of Michigan Polysubstituted benzimidazole nucleosides as antiviral agents
WO1992018517A1 (en) 1991-04-17 1992-10-29 Yale University Method of treating or preventing hepatitis b virus
ZA923641B (en) 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
GB9205071D0 (en) 1992-03-09 1992-04-22 Wellcome Found Therapeutic nucleosides
WO1994008456A1 (en) * 1992-10-21 1994-04-28 The Regents Of The University Of Michigan Polysubstituted benzimidazoles as antiviral agents
GB9226879D0 (en) 1992-12-23 1993-02-17 Iaf Biochem Int Anti-viral compounds
US5399580A (en) 1993-03-08 1995-03-21 Burroughs Wellcome Co. Therapeutic nucleosides-uses
GB9413724D0 (en) 1994-07-07 1994-08-24 Wellcome Found Therapeutic nucleosides
CA2223814A1 (en) 1995-08-18 1997-02-27 John C. Drach 5'-substituted-ribofuranosyl benzimidazoles as antiviral agents
GB9600143D0 (en) * 1996-01-05 1996-03-06 Wellcome Found Therapeutic compounds
US5995610A (en) * 1997-05-06 1999-11-30 Telefonaktiebolaget Lm Ericsson Cooperative call processing across public and private intelligent networks

Also Published As

Publication number Publication date
CZ212698A3 (cs) 1998-12-16
IS4789A (is) 1998-06-30
OA10707A (en) 2001-05-09
CN1214049A (zh) 1999-04-14
TR199801289T2 (en) 1998-10-21
EA199800526A1 (ru) 1999-04-29
EP0876389A1 (en) 1998-11-11
NZ324380A (en) 2000-01-28
GB9600143D0 (en) 1996-03-06
WO1997025337A1 (en) 1997-07-17
PL327732A1 (en) 1998-12-21
US6204249B1 (en) 2001-03-20
AU729541B2 (en) 2001-02-01
BR9612413A (pt) 1999-07-13
AU1164097A (en) 1997-08-01
US6617315B1 (en) 2003-09-09
HUP9904301A2 (hu) 2000-05-28
EA001770B1 (ru) 2001-08-27
NO983090L (no) 1998-09-01
MX9805441A (es) 1998-11-30
CA2241993A1 (en) 1997-07-17
AP9801286A0 (en) 1998-09-30
JP2000515119A (ja) 2000-11-14
KR19990077041A (ko) 1999-10-25
HUP9904301A3 (en) 2001-07-30

Similar Documents

Publication Publication Date Title
DK0769017T3 (da) Terapeutiske forbindelser
NO992806D0 (no) Terapeutiske midler
ID19403A (id) Senyawa-senyawa heterosiklik
ID19609A (id) Senyawa-senyawa heterosiklik
ID16152A (id) Senyawa-senyawa triaril
ID15904A (id) Senyawa-senyawa tiofenopirimidina
ID27841A (id) Turunan-turunan biaril terapeutik
BR9710352A (pt) Compostos piridilpirrole
ID24275A (id) Terapi kombinasi
ID18685A (id) Senyawa trisiklik tersubstitusi
DE69716924D1 (de) Phosphonat-nukleotid-verbindungen
PT906288E (pt) Novos compostos
BR9705635A (pt) Compostos
NO983090D0 (no) Terapeutiske forbindelser
DK0923594T3 (da) Bromotiacumicinforbindelser
DE69709659D1 (de) Halopropargyl-einschlussverbindungen
IS4932A (is) Ný efnasambönd
FI964026L (fi) Hierontalaite
KR960016109U (ko) 신발밑창
KR970053540U (ko) 침시술용 침관
ID19095A (id) Senyawa terapeutik fenetanolamina
NO965332D0 (no) Terapeutisk perparat
ID17103A (id) Senyawa-senyawa sulfonamida
SE9603300D0 (sv) Compounds
SE9600275D0 (sv) Compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application